LIVANOVA DEUTSCHLAND

Manufacturer adverse-event records for LIVANOVA DEUTSCHLAND come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2015–2026 · thin-book · elevated Death-code · injury-light

Death-code intensity

LIVANOVA DEUTSCHLAND carries an elevated Death-code share

Death-coded event_type rows are 145 of 6,113 (2.37% · elevated tercile among 443 manufacturers). Absolute volume is thin-book.

What the Death-code reading shows for LIVANOVA DEUTSCHLAND

The standout signal for LIVANOVA DEUTSCHLAND is Death-code intensity: 2.37% of 6,113 reports (elevated tercile), while absolute volume is thin-book.

As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.

Reports span 12 device types, led in this extract by Malfunction at 5,665 (92.7% of event_type total). Peak single-year volume reaches 906 reports across 12 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

6,113
Total Reports
145
Event-type Death
272
Injury Reports
12
Device Types

Event Types

Malfunction 5,665 (92.7%)
Injury 272 (4.4%)
Death 145 (2.4%)
30 (0.5%)
Other 1 (0.0%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

5,702 (90.8%)
Death 137 (2.2%)
O 132 (2.1%)
Other 124 (2.0%)
Life Threatening 106 (1.7%)
Hospitalization 27 (0.4%)
L 21 (0.3%)
R 12 (0.2%)
D 7 (0.1%)
Required Intervention 5 (0.1%)
H 4 (0.1%)
S 3 (0.0%)
Disability 1 (0.0%)

Yearly Trend

15
2015: 8
16
2016: 60
17
2017: 906
18
2018: 868
19
2019: 890
20
2020: 427
21
2021: 752
22
2022: 687
23
2023: 519
24
2024: 403
25
2025: 562
26
2026: 31